We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/8/2022 17:13 | "A decent chunk for shareholders after creditors is still viable"...Come on buddy that's like wishing on the nigh impossible but good to see that ones still continues to have buckets of optimism! | one_frankel | |
04/8/2022 17:07 | Totally agree .... unbelievable to be honest.... | amaretto1 | |
04/8/2022 17:06 | amaretto, ....all for a banking covenant breach which the Directors should have been aware of and not let happen. | sportbilly1976 | |
04/8/2022 16:54 | DDDD mkt cap 28 million uk !! | amaretto1 | |
04/8/2022 16:52 | I've take that bill from the other bank account..... :-) seriously Seres mkt cap today is nearly 600 million. ..... yes 600 million !! What's DDDD closing price ?? | amaretto1 | |
04/8/2022 16:49 | That's 7m USD. However at 650 GBP per hour that'll soon be gone. | katsy | |
04/8/2022 16:47 | A decent chunk for shareholders (after creditors) is still viable I like that offers have been invited (50 pharmas ) and a deadline set. It fosters a competitive spirit. Its like a tender process. We all got in here believing going forward this was worth billions. Mgt too regularly backed it with their wallets. Lets see how right - or wrong - we were. a £100m+ offer wouldn't suprise. We all wanted a big buyout. How ironic if it happened via this route. | backbone and clingfilm | |
04/8/2022 16:42 | ...Because willing parties are not stupid to pay over the odds albeit in a very concerning market environment and they will fully capitalise on 4Ds desperate situation...Its simply 'Business' to them where nothing else counts unfortunately! | one_frankel | |
04/8/2022 16:40 | Unless there's a bidding war, any one bidding will simply place a take it or leave it offer. 4d admins are not in a bargaining position. | katsy | |
04/8/2022 16:38 | DDDD have still 7 million in the bank They owe 13 million ...Just saying | amaretto1 | |
04/8/2022 16:36 | Won't us share holders get .... what OF have not got the lien on ? It's all very complicated The fact they have asked over 50 bio companies if they want it .....Might ... i mean might ... may spur Merk to do something..Anyway .... still Zero in my head | amaretto1 | |
04/8/2022 16:36 | To be fair to them the Administrators seem to have contacted more potential Pharma/Biotech buyers than 4D's Management ever did. I fail to see how shopping this Company that widely can not lead to a decent bid or refinancing proposal to emerge. Sale of business As alluded to above, we commenced a sale of business process shortly after appointment. We have contacted nearly fifty large pharmaceutical businesses and smaller biotechnology companies (including other prominent players in the microbiome space). Due to the commercial sensitivity of this sales process, we can only provide limited narrative as to the exact progress to date. Offer deadlines have been set with all interested parties and the details of indicative offers received cannot be disclosed subject to confidentiality agreement provisions. Alongside the above sale of business activity, we continue to explore the possibility of a refinance of the Group and an exit from administration. Similarly to above, progress here is confidential and updates will be made available to creditors at the appropriate time. Should no viable offers emerge during the sale of business process, our strategy will likely be to minimise costs to preserve the Company's main asset, floating charge cash, and realise the Company's other assets. | thiopia | |
04/8/2022 16:32 | Its unfortunate but I think so Cornetto and if there was to be any traction for existing investors, it will be for next to nothing, monies will be chewed up with the prolonged process, its standard bloody practice for them. | one_frankel | |
04/8/2022 16:28 | So what's the verdict ? Zero | amaretto1 | |
04/8/2022 16:27 | Dividend to unsecured creditors normally refers to company suppliers, customers, HMRC and contractors but they rank after secured and preferential creditors in an insolvency situation. | one_frankel | |
04/8/2022 16:25 | Seems reasonable no? Administrators are considered the biggest sharks of the lot. | katsy | |
04/8/2022 16:24 | #30012 Shareholders are not classed as unsecured creditors. In effect shareholders are not owed anything by the company, they are beneficial owners of whatever value is left when assets are disposed of after all other classes of creditors are paid off. This is more often than not zilch, given the reason that businesses are usually put into administration is their inability to pay debts as they fall due, and continue to trade, after unsuccessfully exploring other funding options. | monte1 | |
04/8/2022 16:22 | A very interesting and detailed RNS but for all that little progress really. Oxford have achieved their objective though in securing their money. Played it well to be fair to them. | nigelpm | |
04/8/2022 16:19 | RNS states Refinancing is still being explored too. Promising | backbone and clingfilm | |
04/8/2022 16:17 | I've mentally written the lot off | amaretto1 | |
04/8/2022 16:16 | Dividend for unsecured creditors .. what's that ? Share holders | amaretto1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions